The Incidences of KEL Blood Group Antigens and Phenotypes in Southwestern Saudi Arabia.

Kell blood group Saudi Arabia blood transfusion immunohematology

Journal

International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487

Informations de publication

Date de publication:
2024
Historique:
received: 30 07 2024
accepted: 13 09 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: epublish

Résumé

Jazan Province in Saudi Arabia is notable for its high prevalence of inherited hemoglobinopathies, including sickle cell disease and thalassemia, necessitating frequent blood transfusions for affected individuals. To mitigate risks such as RBC alloimmunization and hemolytic transfusion reactions, ensuring blood compatibility is crucial. The Kell (KEL) blood group system, pivotal alongside the ABO and RH systems, encompasses multiple antigens implicated in these complications. This study aimed to investigate the frequencies of KEL blood group antigens (K, k, Kpa, and Kpb) and determine KEL phenotypes (K/k and Kpa/Kpb) among Saudi blood donors living in Jazan Province. A total of 138 anonymous healthy Saudi blood donors from Prince Mohammed bin Nasser Hospital in Jazan Province, Saudi Arabia, were enrolled in this study. Anticoagulated blood was analyzed using the gel card technique to assess K, k, Kpa, and Kpb antigens. The prevalence of KEL antigens was as follows: K (n = 9, 6.52%), k (n = 137, 99.28%), Kpa (n = 1, 0.72%), and Kpb (n = 138, 100%). KEL phenotypes observed were K+k+ (n = 8, 5.80%), K+k- (n = 1 0.72%), K-k+ (n = 129, 93.48%), Kp(a+b+) (n = 1, 0.72%), and Kp(a-b+) (n = 137, 99.28%). This study provides insights into the prevalence of KEL blood group antigens and phenotypes in Jazan Province, Saudi Arabia. These findings may contribute to the establishment of a national blood group database and guide transfusion practices to ensure compatibility and minimize alloimmunization risks.

Identifiants

pubmed: 39308969
doi: 10.2147/IJGM.S489320
pii: 489320
pmc: PMC11416107
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4205-4211

Informations de copyright

© 2024 Halawani et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Amr J Halawani (AJ)

Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.

Hisham I Abu-Tawil (HI)

Department of Laboratory and Blood Bank, Prince Mohammed Bin Nasser Hospital, Ministry of Health, Jazan, Saudi Arabia.
Department of Laboratory and Blood Bank, King Faisal Medical City for Southern Regions, Ministry of Health, Abha, Saudi Arabia.

Salah Alharbi (S)

Armed Forces Hospital in Jazan, Ministry of Defence, Jazan, Saudi Arabia.

Bandar S Almalki (BS)

General Medical Committee, tDirectorate General of Health Affairs, Jazan, Saudi Arabia.

Fawaz M Majmi (FM)

Department of Pharmacy, Ahad Al Masarihah General Hospital, Ministry of Health, Jazan, Saudi Arabia.

Renad A Miny (RA)

Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.

Nada G Alghoribi (NG)

Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.

Sulaiman S Alabsi (SS)

King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Saeed M Kabrah (SM)

Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.

Haneen O Alhaj (HO)

Kholoud Laboratory for Medical Analysis, Makkah, Saudi Arabia.

Musaed M Alshahrani (MM)

Blood Bank Laboratory, Prince Sultan Military Medical City, Saudi Arabia.

Nora Y Hakami (NY)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Classifications MeSH